Brodie AM - Search Results

1

Additive antitumor effect of aromatase inhibitor letrozole and antiestrogen fulvestrant in a postmenopausal breast cancer model.

Jelovac D, Macedo L, Goloubeva OG, Handratta V, Brodie AM. Jelovac D, et al. Among authors: brodie am. Cancer Res. 2005 Jun 15;65(12):5439-44. doi: 10.1158/0008-5472.CAN-04-2782. Cancer Res. 2005. PMID: 15958593

2

Effects of exemestane and tamoxifen in a postmenopausal breast cancer model.

Jelovac D, Macedo L, Handratta V, Long BJ, Goloubeva OG, Ingle JN, Brodie AM. Jelovac D, et al. Among authors: brodie am. Clin Cancer Res. 2004 Nov 1;10(21):7375-81. doi: 10.1158/1078-0432.CCR-04-0565. Clin Cancer Res. 2004. PMID: 15534114

3

Activation of mitogen-activated protein kinase in xenografts and cells during prolonged treatment with aromatase inhibitor letrozole.

Jelovac D, Sabnis G, Long BJ, Macedo L, Goloubeva OG, Brodie AM. Jelovac D, et al. Among authors: brodie am. Cancer Res. 2005 Jun 15;65(12):5380-9. doi: 10.1158/0008-5472.CAN-04-4502. Cancer Res. 2005. PMID: 15958587

4

Stopping treatment can reverse acquired resistance to letrozole.

Sabnis GJ, Macedo LF, Goloubeva O, Schayowitz A, Brodie AM. Sabnis GJ, et al. Among authors: brodie am. Cancer Res. 2008 Jun 15;68(12):4518-24. doi: 10.1158/0008-5472.CAN-07-5999. Cancer Res. 2008. PMID: 18559495 Free PMC article.

5

Functional activation of the estrogen receptor-α and aromatase by the HDAC inhibitor entinostat sensitizes ER-negative tumors to letrozole.

Sabnis GJ, Goloubeva O, Chumsri S, Nguyen N, Sukumar S, Brodie AM. Sabnis GJ, et al. Among authors: brodie am. Cancer Res. 2011 Mar 1;71(5):1893-903. doi: 10.1158/0008-5472.CAN-10-2458. Epub 2011 Jan 18. Cancer Res. 2011. PMID: 21245100 Free PMC article.

6

The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.

Long BJ, Jelovac D, Thiantanawat A, Brodie AM. Long BJ, et al. Among authors: brodie am. Clin Cancer Res. 2002 Jul;8(7):2378-88. Clin Cancer Res. 2002. PMID: 12114443

7

Therapeutic strategies using the aromatase inhibitor letrozole and tamoxifen in a breast cancer model.

Long BJ, Jelovac D, Handratta V, Thiantanawat A, MacPherson N, Ragaz J, Goloubeva OG, Brodie AM. Long BJ, et al. Among authors: brodie am. J Natl Cancer Inst. 2004 Mar 17;96(6):456-65. doi: 10.1093/jnci/djh076. J Natl Cancer Inst. 2004. PMID: 15026471

8

Docetaxel followed by castration improves outcomes in LNCaP prostate cancer-bearing severe combined immunodeficient mice.

Tang Y, Khan MA, Goloubeva O, Lee DI, Jelovac D, Brodie AM, Hussain A. Tang Y, et al. Among authors: brodie am. Clin Cancer Res. 2006 Jan 1;12(1):169-74. doi: 10.1158/1078-0432.CCR-05-1388. Clin Cancer Res. 2006. PMID: 16397039

9

Prolonging hormone sensitivity in prostate cancer xenografts through dual inhibition of AR and mTOR.

Schayowitz A, Sabnis G, Goloubeva O, Njar VC, Brodie AM. Schayowitz A, et al. Among authors: brodie am. Br J Cancer. 2010 Sep 28;103(7):1001-7. doi: 10.1038/sj.bjc.6605882. Epub 2010 Sep 14. Br J Cancer. 2010. PMID: 20842117 Free PMC article.

10

Potent CYP17 inhibitors: improved syntheses, pharmacokinetics and anti-tumor activity in the LNCaP human prostate cancer model.

Handratta VD, Jelovac D, Long BJ, Kataria R, Nnane IP, Njar VC, Brodie AM. Handratta VD, et al. Among authors: brodie am. J Steroid Biochem Mol Biol. 2004 Oct;92(3):155-65. doi: 10.1016/j.jsbmb.2004.07.006. J Steroid Biochem Mol Biol. 2004. PMID: 15555909

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters